{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-042926","form_type":"8-K","ticker":"TELO","cik":"0001971532","company_name":"Telomir Pharmaceuticals, Inc.","filed_at":"2026-09-16T20:30:23+00:00","discovered_at":"2026-09-16T20:31:20.125338+00:00","generated_at":"2026-09-16T20:31:42.043188+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Telomir shareholders elect four directors, ratify auditor at 2026 annual meeting","bullets":["47,129,480 shares voted (68.53% of 68,774,954 outstanding) at Sept 11, 2026 meeting.","Directors elected: Erez Aminov, Matthew Whalen, Edward MacPherson, Matthew Del Giudice, M.D.; votes for ranged from 41.2M to 43.4M.","Ratification of Salberg & Company, P.A. as independent auditor passed with 46,998,583 votes for, 69,548 against.","Adjournment proposal approved: 44,841,042 for, 2,271,263 against, 17,175 abstained."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-042926","json":"https://secwatch.observer/filing/0001493152-26-042926.json","markdown":"https://secwatch.observer/filing/0001493152-26-042926.md","text":"https://secwatch.observer/filing/0001493152-26-042926.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226042926/0001493152-26-042926-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226042926/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-16T20:31:42.043188+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}